novel transcript, antisense to CYP20A1 (ENSG00000289294)

This entry represents a novel or predicted transcript that is antisense to the CYP20A1 gene, annotated as ENSG00000289294 by Ensembl. "Antisense" indicates it is transcribed in the opposite direction to the coding CYP20A1 gene, and "novel transcript" usually means its function, expression, and relevance are unknown or uncharacterized. Such transcripts are often detected by high-throughput sequencing but may have no protein product or proven function. There is no evidence it is a therapeutic target, nor is there information about disease relevance, interacting drugs, or mechanism of action. This entry is thus primarily of genomic annotation interest and not biomedical targeting relevance[5]. If further research provides evidence of function, the molecular classification or disease role may be updated, but as of now, it is not considered a validated biomedical target.

Other names

ENSG00000289294antisense transcript to CYP20A1